Two Sigma Investments’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-63,181	Closed	-$250K	–	2579
2018 Q4	$250K	Buy	63,181 +51,301	+432%	+$203K	﹤0.01%	1811
2018 Q3	$235K	Buy	+11,880	New	+$235K	﹤0.01%	1826
2018 Q1	–	Sell	-2,970	Closed	-$235K	–	2539
2017 Q4	$235K	Buy	+2,970	New	+$235K	﹤0.01%	1992